Clinical Trials Logo

Celecoxib clinical trials

View clinical trials related to Celecoxib.

Filter by:
  • None
  • Page 1

NCT ID: NCT05509946 Not yet recruiting - Clinical trials for Arthroplasty Complications

Preemptive Analgesia Combination of Celecoxib and Pregabalin in THA

Start date: October 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This is a double-blinded randomized controlled trial aims to evaluate the effect of preemptive analgetic combination of celecoxib and pregabalin to acute pain after total hip arthroplasty. This study will be conducted in Cipto Mangunkusumo Hospital, Jakarta, Indonesia, from October 2022 to April 2023. The subject of this study is adult patient who will be performed total hip arthroplasty.

NCT ID: NCT00474773 Completed - Pain Management Clinical Trials

Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery

Start date: June 2007
Phase: Phase 4
Study type: Observational

This study will evaluate the benefits of continuing celecoxib through six weeks of total knee arthroplasty recovery. This is a randomized, double blind study with a group of approximately 130 primary total knee patients. All patients will receive celecoxib throughout their hospitalization as per current minimally invasive total knee arthroplasty protocol. At the time of hospital discharge, participating patients will be randomly placed on either celecoxib 200mg twice a day or a placebo twice a day. This study will determine if the continued use of celecoxib for six weeks after total knee arthroplasty hospitalization will further decrease narcotic consumption, improve knee range of motion, improve ambulatory ability, and improve patient satisfaction over patients receiving celecoxib only during the acute hospitalization.